In this free webinar, learn about the current landscape as well as the future of regulatory submissions, including the emerging trends in regulatory writing such as generative artificial intelligence (AI), automation and lean writing. Attendees will gain insights into the regulatory expectations with AI and maintaining standards of compliance. The featured speakers will explore how these trends will increase the speed and quality of submission documents.
TORONTO, May 22, 2024 /PRNewswire-PRWeb/ -- This informative webinar is aimed to be forward-looking, discuss the potential promises of emerging technological tools in expediting and radically changing submission preparation, pinpoint potential challenges and brainstorm resolutions.
The current landscape of regulatory submissions is weighed down by the sheer volume of documentation required, complex guidelines and repetitive information across documents. It also involves the painstaking, cumbersome writing styles and processes necessitating multiple rounds of reviews on the same content across documents, increasing costs and jeopardizing efficiency and quality, thereby adding to the already long cycle times of drugs from bench to bedside.
In the regulatory writing sphere, generative artificial intelligence (AI), automation, structured authoring, collaborative authoring and lean writing are slowly making their way into how work is accomplished. These tools in turn will lead to fast, efficient and robust filing of marketing authorization applications. Thus, there is a possibility of a paradigm shift in the field, a change that is all radiant and promising, albeit requiring wise use of these applications.
As these concepts and styles are incorporated into how submissions are approached, the following changes are expected in the field:
- Radically enhance the speed and quality of the submission documents
- Free up highly skilled and qualified medical writers from redundant transactional jobs and engage them more "intelligently" — to program the automation drivers and generative AI tools efficiently
- Bring forward approval timelines and thus increase the reach of drugs to waiting patients faster
- Help shape the regulatory landscape allowing for innovation with AI
Register for this webinar today to gain insights into the potential promise of emerging AI tools in expediting and radically changing how regulatory submissions are prepared.
Join experts from Allucent, Sugato De, Vice President, Regulatory Strategy, Head of Medical Technology, Ernesto Vera-Sanchez, Vice President, Division Head GxP Strategy; and Sushmita Bhattacharya, Sr. Director, Medical Writing, for the live webinar on Thursday, June 6, 2024, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit The Changing Paradigm of Regulatory Submissions: Embracing Automation, Gen AI, and Innovation for Faster Approvals.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Soumya Shashikumar, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com
SOURCE Xtalks
Share this article